First Financial Bankshares Inc Decreases Stock Position in Danaher Corporation $DHR

Key Points

• First Financial Bankshares Inc significantly reduced its stake in Danaher Corporation by selling 41,532 shares, resulting in a 97.4% decrease in its holdings, bringing its total to just 1,128 shares valued at $231,000.
• Several institutional investors have increased their investments in Danaher, with Bank Pictet & Cie Europe AG raising its holdings by 22.8% during the last quarter.
• Analyst ratings for Danaher show a consensus of "Moderate Buy" with a target price averaging $247.61, indicating a positive outlook despite recent adjustments to price objectives from various analysts.

First Financial Bankshares Inc reduced its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 97.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,128 shares of the conglomerate's stock after selling 41,532 shares during the period. First Financial Bankshares Inc's holdings in Danaher were worth $231,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter valued at about $27,000. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC grew its stake in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher during the 1st quarter valued at about $31,000. Finally, Dunhill Financial LLC grew its stake in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. Evercore ISI dropped their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Wells Fargo & Company lowered their target price on Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lowered their target price on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Royal Bank Of Canada set a $241.00 target price on Danaher in a research note on Tuesday. Finally, Barclays restated an "overweight" rating and issued a $225.00 target price (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Price Performance

DHR traded up $1.29 during trading on Friday, hitting $200.32. The company's stock had a trading volume of 2,837,584 shares, compared to its average volume of 2,859,442. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The business's fifty day simple moving average is $201.93 and its 200 day simple moving average is $199.41. The firm has a market capitalization of $143.44 billion, a price-to-earnings ratio of 42.62, a P/E/G ratio of 2.78 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period last year, the company earned $1.72 earnings per share. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.